The COVID-19 pandemic has affected U.S. health care in an unprecedented way, requiring hospitals, providers, and suppliers to collaborate to respond to the urgency of the crisis. The situation has also put pressure on...more
The COVID-19 crisis has led to increased scrutiny of pricing decisions by competition and consumer protection authorities around the world. Already, we have seen a rise in state, federal, and international enforcement efforts...more
4/24/2020
/ Antitrust Provisions ,
Antitrust Violations ,
Coronavirus/COVID-19 ,
Corruption ,
EU ,
Goods or Services ,
Manufacturers ,
Price Gouging ,
Price Inflation ,
Sales & Distribution Agreements ,
Supply Chain ,
Unfair or Deceptive Trade Practices ,
White Collar Crimes
On 24 March 2020 the Antitrust Division of the Department of Justice (DOJ) and the Bureau of Competition of the Federal Trade Commission (FTC) (collectively the agencies) released a joint statement providing guidance to the...more